Publication Name	World Journal of Hepatology
Manuscript ID	32952
Country	Greece

Received	2017-02-01 13:57
Peer-Review Started	2017-02-08 14:24
First Decision by Editorial Office Director
Return for Revision	2017-06-12 01:30
Revised	2017-07-18 08:04
Publication Fee Transferred
Second Decision by Editor	2017-08-11 07:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2017-08-16 17:54
Articles in Press	2017-08-16 17:54
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-09-05 02:37
Publish the Manuscript Online	2017-09-07 02:39

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Hepatitis B in renal transplant patients
Manuscript Source	Invited Manuscript
All Author List	Smaragdi Marinaki, Kyriaki Kolovou, Stratigoula Sakellariou, John N Boletis and Ioanna K Delladetsima
Funding Agency and Grant Number
Corresponding Author	Ioanna K Delladetsima, PhD, Professor, First Department of Pathology, Medical School, University of Athens, Mikras Asia 75, Goudi, Athens 11527, Greece. idelladet@med.uoa.gr
Key Words	Hepatitis B virus (+) donor; Hepatitis B virus (+) recipient; Renal transplantation; Viral reactivation; Immunosuppression; Nucleoside analogues; Antiviral discontinuation; Antiviral prophylaxis; Hepatitis B
Core Tip	Though decreasing, hepatitis B still remains a considerable problem, especially in high-risk patient populations as kidney transplant recipients. The widespread use of new antivirals and the introduction of universal prophylaxis immediately after transplantation have changed the picture in hepatitis B virus (HBV) (+) transplantation. Long term survival rates of HBV(+) recipients are approaching those of HBV(-), altering HBV(+) kidney transplantation from a “high risk” procedure into routine practice. Furthermore, accumulating evidence confirms the safety of trans­plantation from HBsAg(+) donors into immunized recipients. All immunosuppressants can be used in HBV(+) transplantation and total immunosuppression must be kept at the lowest possible levels long term.
Publish Date	2017-09-07 02:39
Citation	Marinaki S, Kolovou K, Sakellariou S, Boletis JN, Delladetsima IK. Hepatitis B in renal transplant patients. World J Hepatol 2017; 9(25): 1054-1063
URL	http://www.wjgnet.com/1948-5182/full/v9/i25/1054.htm
DOI	http://dx.doi.org/10.4254/wjh.v9.i25.1054

Full Article (PDF)	WJH-9-1054.pdf
Full Article (Word)	WJH-9-1054.doc
Manuscript File	32952-Review.doc
Answering Reviewers	32952-Answering reviewers.pdf
Audio Core Tip	32952-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	32952-Conflict-of-interest statement.pdf
Copyright License Agreement	32952-Copyright assignment.pdf
Peer-review Report	32952-Peer-review(s).pdf
Scientific Misconduct Check	32952-Scientific misconduct check.pdf
Scientific Editor Work List	32952-Scientific editor work list.pdf